Ethyne

Ethyne

SCHEMBL165176

C#C.CCCOC(=O)OCCC

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
HCAR2 Q8TDS4 1/20 0.44
LMNA P02545 2/20 0.41
TSHR P16473 2/20 0.40
ESR1 P03372 1/20 0.40
CHRM1 P11229 1/20 0.40
SLC6A2 P23975 1/20 0.40
KDR P35968 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SOAT1 P35610 1/20 0.39
ATM Q13315 1/20 0.37
NAAA Q02083 1/20 0.36
DGKA P23743 1/20 0.36
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
ALOX5 P09917 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HPGD P15428 1/20 0.34
ACHE P22303 1/20 0.34
PPM1B O75688 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17057 0.94 ALDH1A1 (0.56) ALDH1A1HCAR2LMNATSHRESR1
Ethane SCHEMBL28190088 0.91 ALDH1A1 (0.53) ALDH1A1HCAR2LMNATSHRESR1
Fluoride SCHEMBL29068323 0.91 ALDH1A1 (0.53) ALDH1A1HCAR2LMNATSHRESR1
SCHEMBL6934821 0.91 ALDH1A1 (0.53) ALDH1A1HCAR2LMNATSHRESR1
SCHEMBL13465919 0.91 ALDH1A1 (0.53) ALDH1A1HCAR2LMNATSHRESR1
Hydrogen Peroxide SCHEMBL28922349 0.91 ALDH1A1 (0.53) ALDH1A1HCAR2LMNATSHRESR1
Ethylene SCHEMBL29245194 0.88 ALDH1A1 (0.50) ALDH1A1HCAR2LMNATSHRESR1
Bicarbonate SCHEMBL278365 0.88 ALDH1A1 (0.50) ALDH1A1HCAR2LMNATSHRESR1
Bicarbonate SCHEMBL21462683 0.88 ALDH1A1 (0.50) ALDH1A1HCAR2LMNATSHRESR1
Ethyne SCHEMBL5537552 0.87 HCAR2 (0.40) ALDH1A1HCAR2LMNATSHRESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4730479-A2 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME Kyoto University (JP) 2026-04-22 EP disclosed
US-20260031394-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2026-01-29 US disclosed
US-20260031400-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2026-01-29 US disclosed
US-20250246685-A1 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME KYOTO UNIVERSITY (JP) 2025-07-31 US disclosed
WO-2025110163-A1 POSITIVE ELECTRODE FOR NONAQUEOUS ELECTROLYTE POWER STORAGE ELEMENTS, AND NONAQUEOUS ELECTROLYTE POWER STORAGE ELEMENT 株式会社GSユアサ 2025-05-30 WO disclosed
WO-2025095088-A1 NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED WITH SAID SOLUTION ステラケミファ株式会社 2025-05-08 WO disclosed
EP-4525122-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME Tomiyama Pure Chemical Industries, Limited (JP) 2025-03-19 EP disclosed
EP-4525123-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME Tomiyama Pure Chemical Industries, Limited (JP) 2025-03-19 EP disclosed
WO-2025023169-A1 NONAQUEOUS ELECTROLYTE POWER STORAGE ELEMENT AND METHOD FOR MANUFACTURING SAME 株式会社GSユアサ 2025-01-30 WO disclosed
US-12191448-B2 Nonaqueous electrolyte solution for secondary battery, and secondary battery provided with said solution STELLA CHEMIFA CORPORATION (JP) 2025-01-07 US disclosed
EP-2611732-A1 POROUS ELECTROACTIVE MATERIAL Nexeon Limited (GB) 2013-07-10 EP disclosed
CN-103069636-A Nonaqueous electrolyte solution, method for producing same, and nonaqueous electrolyte battery using the electrolyte solution WAKO PURE CHEM IND LTD 2013-04-24 CN disclosed
US-20130069601-A1 ADDITIVE FOR LITHIUM ION RECHAGEABLE BATTERY CELLS SK ON CO., LTD. (KR) 2013-03-21 US disclosed
EP-2430686-A1 AN ADDITIVE FOR LITHIUM ION RECHARGEABLE BATTERY CELLS Nexeon Limited (GB) 2012-03-21 EP disclosed
WO-2012028857-A1 POROUS ELECTROACTIVE MATERIAL NEXEON LIMITED (GB) 2012-03-08 WO disclosed
CN-101297433-B Inhibitor for life cycle reduction of redox shuttle additive, and non-aqueous electrolyte and secondary battery comprising the same LG CHEM, LTD. (KR) 2011-12-21 CN disclosed
CN-102113163-A Nonaqueous electrolyte solution and lithium secondary battery MITSUI CHEMICALS INC 2011-06-29 CN disclosed
US-20110136006-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY MITSUI CHEMICALS INC. (JP) 2011-06-09 US disclosed
EP-2320501-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY Mitsui Chemicals, Inc. (JP) 2011-05-11 EP disclosed
CN-101297433-A Inhibitor for life cycle reduction of redox shuttle additive, and non-aqueous electrolyte and secondary battery comprising the same LG CHEMICAL LTD (KR) 2008-10-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260031394-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME SMC1A, SMC2, SMC4 ALDH1A1 3714/4885HCAR2 4796/4885LMNA 1364/4885
US-20260031400-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME KCNN1, KCNN2, ILK ALDH1A1 3090/4885HCAR2 4673/4885LMNA 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.